| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.52B | 3.55B | 3.67B | 3.84B | 3.43B | 3.40B |
| Gross Profit | 1.81B | 1.81B | 1.83B | 1.79B | 1.68B | 1.63B |
| EBITDA | 1.11B | 1.11B | 1.10B | 930.00M | 751.00M | 1.01B |
| Net Income | 441.00M | 434.00M | 378.00M | 242.00M | 177.00M | 330.00M |
Balance Sheet | ||||||
| Total Assets | 6.22B | 6.89B | 6.73B | 7.31B | 7.34B | 7.45B |
| Cash, Cash Equivalents and Short-Term Investments | 347.00M | 543.00M | 312.00M | 558.00M | 937.00M | 1.10B |
| Total Debt | 1.50B | 1.47B | 1.16B | 1.24B | 1.40B | 1.65B |
| Total Liabilities | 2.62B | 2.84B | 2.74B | 2.91B | 3.06B | 3.32B |
| Stockholders Equity | 3.59B | 4.04B | 3.97B | 4.40B | 4.27B | 4.13B |
Cash Flow | ||||||
| Free Cash Flow | 624.00M | 503.00M | 399.00M | 304.00M | 150.00M | 255.00M |
| Operating Cash Flow | 744.00M | 627.00M | 525.00M | 361.00M | 326.00M | 389.00M |
| Investing Cash Flow | -74.00M | -131.00M | -301.00M | 13.00M | -80.00M | 591.00M |
| Financing Cash Flow | -606.00M | -241.00M | -450.00M | -804.00M | -414.00M | -299.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $12.26B | 36.12 | ― | 0.95% | 8.43% | 21.38% | |
74 Outperform | $7.85B | 14.63 | 11.74% | 2.11% | 1.93% | 34.40% | |
69 Neutral | $1.56B | 15.73 | 13.61% | 4.48% | -5.33% | ― | |
65 Neutral | $829.91M | ― | -0.35% | 2.78% | 2.53% | -23.86% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
58 Neutral | $11.92M | 2.89 | -11.27% | ― | -30.65% | -62.03% |
On 14 January 2026, activist investor Cevian Capital II GP Limited increased its stake in Pearson plc, crossing a UK disclosure threshold as its indirect voting interest rose from 14.17% to 15.26%, equivalent to 97,043,459 voting rights, with the holding legally registered under Aurora Nominees Limited on behalf of UBS AG as custodian. The move, formally notified to Pearson on 16 January 2026 and completed in Jersey, further consolidates Cevian’s position as a major shareholder in the education group, potentially giving it greater influence over corporate governance, strategy and capital allocation, and underscoring continued investor scrutiny of Pearson’s performance and transformation efforts.
The most recent analyst rating on (PSO) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Pearson stock, see the PSO Stock Forecast page.
On 16 January 2026, Pearson plc filed a block listing return covering activity between 1 December 2025 and 15 January 2026 for two of its employee share schemes, providing an update on the use of previously authorised share capital. Under its Save for Shares Plan, the company allotted 41,942 shares during the period, reducing the balance of unallotted securities under that scheme from 1,482,109 to 1,440,167, while no shares were issued under the Employee Stock Purchase Plan, leaving its unallotted balance unchanged at 2,228,992 shares. The disclosures indicate modest utilisation of shares for employee incentives without any increase in the size of the underlying block listings, suggesting Pearson is continuing to support staff participation in equity schemes within existing shareholder authorisations rather than expanding its potential dilution.
The most recent analyst rating on (PSO) stock is a Hold with a $15.50 price target. To see the full list of analyst forecasts on Pearson stock, see the PSO Stock Forecast page.